340B Advocacy Alliance Bulletin
Please contact your representatives today and ask them to sign onto a bipartisan “Dear Colleague” letter to Xavier Becerra, the nominee for Department of Health and Human Services Secretary, asking him to take immediate action to ensure that manufacturers are prohibited from imposing unilateral…
Yesterday counsel for AHA and the four other national groups participants and three individual hospital systems that sued the Department of Health and Human Services over its failure to halt drug company actions that undermine the 340B program sent letters demanding that the offending…
The Department of Health and Human Services Office of the General Counsel Dec.
Attorneys general in 27 states and Washington, D.C., today
The AHA, joined by four other national hospital groups and an organization of hospital pharmacists representing participants in the 340B drug pricing program, yesterday filed a federal lawsuit against the Department of Health and Human Services over the department’s failure to enforce program…
The Health Resources and Services Administration Dec.
The Health Resources and Services Administration today released its long-awaited
The AHA on Friday sent a letter to the Health Resources and Services Administration’s Office of Pharmacy Affairs urging the agency to order drug manufacturers and their vendor Kalderos to immediately halt their conversion of the 340B program to a back-end rebate program.
The AHA today submitted
The full U.S. Court of Appeals for the District of Columbia Circuit Oct. 16 denied AHA’s request to reconsider two decisions from this summer that upheld the Centers for Medicare & Medicaid Services’ cuts to payments for 340B drugs and for off-campus hospital outpatient clinic visits.